bioAffinity to present CyPath Lung data at NAVREF 2026 conference
bioAffinity Technologies says it will present two posters on its noninvasive lung cancer diagnostic CyPath® Lung at the NAVREF 2026 Annual Conference.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.